Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells for Immune Reconstitution in HIV-infected Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating umbilical cord-derived mesenchymal stem cells for immune reconstitution in HIV-infected patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection
• Immune Reconstitution Inflammatory Syndrome

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Fu-Sheng Wang | Conditions: Human Immunodeficiency Virus, Disorder of Immune Reconstitution | Phase 2 | Status: UNKNOWN